Daniela Alfano Selected Research

NSC48478

7/2015

Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Alfano Research Topics

Disease

7	Neoplasms (Cancer) 07/2015 - 02/2005
2	Carcinoma (Carcinomatosis) 05/2012 - 01/2009
2	Neoplasm Metastasis (Metastasis) 01/2009 - 02/2005
1	Melanoma (Melanoma, Malignant) 01/2015
1	Cholera 02/2013

Drug/Important Bio-Agent (IBA)

4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2012 - 06/2006
3	Urokinase Plasminogen Activator ReceptorsIBA 05/2012 - 06/2006
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 02/2013
1	Laminin (Merosin)IBA 07/2015
1	NSC48478IBA 07/2015
1	1-((4-methoxyanilino)methyl)-2-naphtholIBA 07/2015
1	Laminin ReceptorsIBA 07/2015
1	Okadaic AcidIBA 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2015
1	Temozolomide (Temodar)FDA LinkGeneric 01/2015
1	Peptides (Polypeptides)IBA 02/2013
1	IntegrinsIBA 02/2013
1	PhosphoproteinsIBA 07/2012
1	Apoptosis Regulatory ProteinsIBA 07/2012
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 05/2012
1	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2011
1	integrin alphaVbeta5IBA 01/2009
1	Serine Proteases (Serine Protease)IBA 06/2006
1	Fibrinolysin FDA Link 02/2005
1	PlasminogenIBA 02/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2005

Therapy/Procedure

1	Therapeutics 01/2009